ERCC1, p16, and Ki-67 immunohistochemichal expression as predictive and prognostic markers in head and neck squamous cell carcinoma treated with platin-based induction chemotherapy: Staining with the two anti-ERCC1 antibodies (8F1 and FL-297) was compared.

Hélène Roussel,M. Housset,Helene Tournat,Patrice Ravel,Stéphane Hans,Patrick Bruneval,Cécile Badoual

ERCC1, p16, and Ki-67 immunohistochemichal expression as predictive and prognostic markers in head and neck squamous cell carcinoma treated with platin-based induction chemotherapy: Staining with the two anti-ERCC1 antibodies (8F1 and FL-297) was compared.

2012

Hélène Roussel
M. Housset
Helene Tournat
Patrice Ravel
Stéphane Hans
Patrick Bruneval
Cécile Badoual

e13578 Background: Head and neck squamous cell carcinoma (HNSCC) treatment had undergone important changes, in particular due to the organ preservation and the advent of chemotherapy, particularly ...

Keywords:

Antibody
Ki-67
ERCC1
Staining
Head and neck squamous-cell carcinoma
Cancer research
Induction chemotherapy
Pathology
Medicine
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations